Genetic polymorphism in N-Acetyltransferase (NAT): Population distribution of NAT1 and NAT2 activity.
about
New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?Isoniazid metabolism and hepatotoxicityAddressing human variability in next-generation human health risk assessments of environmental chemicalsVariation in PAH-related DNA adduct levels among non-smokers: the role of multiple genetic polymorphisms and nucleotide excision repair phenotypeN-Acetyltransferase 1 (NAT1) Genotype: A Risk Factor for Urinary Bladder Cancer in a Lebanese PopulationArylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazineRed meat intake, NAT2, and risk of colorectal cancer: a pooled analysis of 11 studiesN-acetyltransferase 2 polymorphisms and risk of esophageal cancer in a Chinese population.NAT2 gene polymorphisms in three indigenous groups in the Colombian Caribbean Coast regionPharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapyPredictors of acute chemotherapy-associated toxicity in patients with Ewing sarcomaReduced antituberculosis drug concentrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines.Isoniazid pharmacokinetics, pharmacodynamics, and dosing in South African infants.Red-Brown Urine Discolouration in Two Patients Taking Mesalamine.Genetic polymorphism in metabolism and host defense enzymes: implications for human health risk assessment.Arylamine N-acetyltransferases: a structural perspective.Toxicogenetic profile and cancer risk in Lebanese.Extrahepatic metabolism at the body's internal-external interfaces.Occupational bladder cancer: Polymorphisms of xenobiotic metabolizing enzymes, exposures, and prognosis.N-Acetyltransferase 2 and glutathione s-transferase M1 in colon and rectal cancer cases from an industrialized area.N-acetyltransferase 1*10 genotype in bladder cancer patients.Profile of rociletinib and its potential in the treatment of non-small-cell lung cancer.NAT2 polymorphisms and risk for Parkinson's disease: a systematic review and meta-analysis.Association of NAT2 polymorphisms with risk of colorectal adenomas: Evidence from 3,197 cases and 4,681 controls.Sex, ethnicity, and slow acetylator profile are the major causes of hepatotoxicity induced by antituberculosis drugs.N-acetyltransferase 2 genetic variants confer the susceptibility to head and neck carcinoma: evidence from 23 case-control studies.Metabolic profiling of TRPV1 antagonists of the benzothiazole amide series: implications for in vitro genotoxicity assessment.A framework and case studies for evaluation of enzyme ontogeny in children's health risk evaluation.NAT2 polymorphisms with oral carcinoma susceptibility: a meta-analysis.Distribution and Role of N-acetyltransferase 2 Genetic Polymorphisms in Bladder Cancer Risk in a Lebanese PopulationNAT1 genotypic and phenotypic contribution to urinary bladder cancer risk: a systematic review and meta-analysis.Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.Genetic polymorphisms of arylamine N-acetyltransferases 1 and 2 and the likelihood of developing pediatric acute lymphoblastic leukemia.N-acetyl transferase 2/environmental factors and their association as a modulating risk factor for sporadic colon and rectal cancer.Comparison of xenobiotic metabolizing enzyme activities in ex vivo human skin and reconstructed human skin models from SkinEthic.Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patients.NAT2 Gene Polymorphisms in Turkish Patients with Psoriasis Vulgaris.
P2860
Q28075511-19599946-34EB-4A58-ABBE-8B6741A9BD96Q28076859-FE9B35DD-9EF2-413A-97B5-EDB8B7EED979Q28393541-BA34CA73-B168-4FBA-A44A-979E28544798Q28395636-D01C7C0D-A510-4788-BD62-B9EB92792E4EQ28728127-5B4D5E0C-3A94-4A09-BC88-D8C9E626705DQ34587103-F69A3366-D0D3-40E6-8606-9973CBF382ADQ34964012-B956F54C-721E-4782-8E81-BC12EBD63899Q35105979-BDA3DE8C-C03E-490D-B7AF-BE86EC37E50AQ35149733-64F679B2-91B7-4311-8FB5-3F1A6E42C709Q35654120-37115803-84AF-4017-AF33-C6E307632BDEQ35848369-E1041AF4-79BB-42E1-997F-5857A37D8780Q36018761-2233BE42-FAFB-430D-895A-4EDF3024093BQ36097299-072E95AE-C088-4410-B8DB-0B087036DA14Q37219195-77E3ECEA-76FB-4891-8CBB-6973E062804BQ37775981-5BB8D605-DF89-4CF3-9005-4DDB76A6B67BQ38091708-F5B2960A-87C4-4B6E-AD4B-729F205C4357Q38195853-9418996A-B63C-477F-B71F-64B906C9659FQ38199198-A2682578-EEAB-40FF-BE41-8503015CF318Q38399984-BD6E7F98-7C7F-43E3-9D34-D2B7E133AD4AQ38432183-674DC0AB-A6FF-433B-85B9-225CA835BF3BQ38684208-F3A8ABEF-0C72-49BA-A012-A77E57D5B380Q38756349-62559D62-EF89-49F9-9C55-5135BD5E8919Q38842411-E5A6E881-BA32-4F4B-BDD4-3500574AF6D2Q41318734-AF66C4FA-1363-481F-841B-F81A446A9F36Q42284821-FB6BE787-A98E-4B01-8A66-60334C27DA5CQ44997557-33A20191-2C78-4DC0-BA66-4102B147B0DAQ46163389-5C9F145F-CCD2-4448-A53D-41951351750BQ47254105-D39FC788-453D-459A-BDB6-3FBD6F07E6CFQ47590240-76BB362D-264F-4F9A-951C-937A4EAF39A4Q47914768-95B65711-0C5A-4468-9BE9-2050E79B343EQ48093037-C83B6DFD-BEB2-4C5B-AC44-34826199D10BQ48123467-E2EB958D-433F-416D-BF85-1F29BC62B94DQ48161555-01C99F53-BB60-4E35-B908-5474D883868EQ50222855-BE45C132-BC54-456B-BE5B-5555C9BCE1FFQ53592187-7F1D5412-193A-4700-957E-9B663B01C6C8Q53765768-5579C72D-1AA0-4715-B1B7-B86C955DF110Q55501446-F28603FA-347D-4713-9243-2F6ED45A896A
P2860
Genetic polymorphism in N-Acetyltransferase (NAT): Population distribution of NAT1 and NAT2 activity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genetic polymorphism in N-Acet ...... ion of NAT1 and NAT2 activity.
@en
Genetic polymorphism in N-Acetyltransferase
@nl
type
label
Genetic polymorphism in N-Acet ...... ion of NAT1 and NAT2 activity.
@en
Genetic polymorphism in N-Acetyltransferase
@nl
prefLabel
Genetic polymorphism in N-Acet ...... ion of NAT1 and NAT2 activity.
@en
Genetic polymorphism in N-Acetyltransferase
@nl
P2093
P2860
P1476
Genetic polymorphism in N-Acet ...... ion of NAT1 and NAT2 activity.
@en
P2093
Babasaheb Sonawane
Dale Hattis
Douglas O Johns
Gary Ginsberg
Kathryn Z Guyton
Katy Walker
P2860
P304
P356
10.1080/10937400903158383
P577
2009-01-01T00:00:00Z